Vita 34 AG Namens-Aktien o.N.
- BID
2.71
- ASK
3.01
- 1,292 Units1,163 Units
- 07/21, 19:16:05 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
38.57%
Market Cap
49.85 Mil.
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.36 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 2.71 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 07:16:05 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 2.92 | 2.71 |
| PREV. DAY'S PRICE | 2.86 | (07/20) |
| CHANGE DAY BEFORE | -0.15 | -5.24 % |
| 52 WEEK HIGH / LOW | 7.5 (08/27) | 2.9 (07/08) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.12 | -0.70 | -0.36 | 0.01 | 0.06 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | 302.00 | 50.33 |
PRICE - BOOK RATIO | 3.88 | 5.08 | 14.70 | - | - |
PRICE - SALES RATIO | 1.08 | 0.87 | 1.19 | - | - |
PRICE - CASH FLOW RATIO | 9.00 | 8.13 | 26.97 | - | - |
Master Data
| WKN | A0BL84 |
| ISIN | DE000A0BL849 |
| SYMBOL | V3V |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Vita 34 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 17.43 Mil. |
| MARKET CAPITALISATION | 49.85 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -4.75 % | -19.30 % | -33.41 % | -47.65 % | -38.57 % | -39.44 % | -81.30 % | -48.98 % |
| HIGH | 3.16 | 3.80 | 4.52 | 5.85 | 7.50 | 7.50 | 17.40 | 6.00 |
| LOW | 2.92 | 2.90 | 2.90 | 2.90 | 2.90 | 2.90 | 2.90 | 2.90 |
Dividende
pro Aktie
Vita 34 does not deliver dividend information
Company profile
FamiCord AG engages in the collection, logistics, processing, and storage of stem cells from umbilical cord blood, umbilical cord tissue, and other postnatal tissues, serving as a full-service provider for cryopreservation. It also engages in the development of products and drugs derived from cells, tissues, and blood for medical applications. Additionally, FamiCord is active in Cell & Gene therapies and operates as a CDMO. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
(in 38 days)
08/28/26Q2 2026 Earnings Release
(in 125 days)
11/23/26Q3 2026 Earnings Release
(in 288 days)
05/05/27Q4 2026 Earnings Release
(in 316 days)
06/02/27Q1 2027 Earnings Release
(in 406 days)
08/31/27Q2 2027 Earnings Release